Close

Concordia International (CXRX) Misses Q3 EPS by 35c; Guidance Suspended

Go back to Concordia International (CXRX) Misses Q3 EPS by 35c; Guidance Suspended

RBC Capital Downgrades Concordia Healthcare (CXRX) to Sector Perform

November 8, 2016 6:20 AM EST

RBC Capital downgraded Concordia Healthcare (NASDAQ: CXRX) from Outperform to Sector Perform with a price target of $2.50 (from $10.00) as the US Legacy business significantly underperformed largely due to pricing issues.

Analyst Douglas Miehm commented, "are downgrading Concordia to Sector perform as we believe risks are increasing materially and visibility is worsening. In... More

Canaccord Genuity Downgrades Concordia Healthcare (CXRX) to Sell

November 7, 2016 1:24 PM EST

Canaccord Genuity downgraded Concordia Healthcare (NASDAQ: CXRX) from Spec. Buy to Sell with a price target of $1.00.

For an analyst ratings summary and ratings history on Concordia Healthcare click here. For more ratings news on Concordia Healthcare click here.

Shares of Concordia Healthcare closed at $3.19 yesterday.

... More